Trimethoprim-sulphamethoxazole mixtures and agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced*; D000890:Anti-Infective Agents / Q000009:adverse effects*; D004427:Ear Diseases / Q000188:drug therapy; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects*; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole